PV24 Speakers

Subject to change.

 

 

image

Juan Retamero, MD

Medical Vice President, Pathology Operations for Diagnostics, Paige


Dr. Juan Retamero is an anatomical pathologist with extensive experience in the implementation and use of digital pathology and artificial intelligence in clinical use. He played a key role in the adoption of digital pathology for routine diagnosis in a pioneering group of hospitals in 2016. Since then, he has shared his experiences worldwide and has supported many centers in the adoption of digital pathology, including labs in the United States and many countries in Europe and Asia.

 

 

SESSIONS

[PathPresenter] Lessons from the Frontlines: Navigating Integration of LIS, IMS, and AI in Pathology
   Sun, Nov 3
   01:30PM - 02:30PM ET
  Regency P

The Preconference workshop at Pathology Visions, presented by PathPresenter (an IMS company), Paige (a leader in AI models for pathology), and the MSKCC Pathology Department, aims to address the evolving landscape of digital pathology in academic settings and lessons learnt from the experience. The session opens with insights from Dr. Ardon at MSKCC, highlighting the unique goals and challenges faced by academic centers during rapid digital pathology expansion, including integration with Epic Beaker and the complexities encountered during their RFP process. This sets the stage for PathPresenter's exploration of interoperability within image management systems (IMS), focusing on the critical integration issues with large-scale systems like Epic. Emphasis is placed on how MSKCC's needs extend beyond primary diagnosis to encompass consultations, education, and research.

AI is set to drive further enhancements to the world of pathology and when considering the digital pathology business case, cannot be an afterthought.  Paige will present their cutting-edge clinical AI products, and how integration with case management and workflows like PathPresenter can make AI central to digital diagnostic review. This will include diagnostic applications like the Paige Breast portfolio - and other multi cancer screening tools for case prioritization.  This review will also include new and upcoming AI applications like Omniscreen and Alba, which are truly changing the face of digital pathology. 

The discussion concludes by underscoring the significance of an end-to-end solution and the necessity for collaborative efforts between leading innovative companies to work together with the goal of maximizing utility for institutions like MSKCC and other organizations.

[Paige] Are AI Co-Pilots the Future of Pathology? Discover the Potential with Paige Alba™
   Sun, Nov 3
   02:45PM - 03:45PM ET
  Regency P

Curious about how innovative AI can transform the way you work by seamlessly integrating real-time insights and streamlining every aspect of your day? Join us to discover how Paige Alba™, the cutting-edge clinical-grade co-pilot, can automate routine tasks, provide real-time insights and revolutionize the way pathology is practiced.

Chat bot